Email updates

Keep up to date with the latest news and content from BMC Clinical Pathology and BioMed Central.

Open Access Technical advance

Dual color chromogenic in situ hybridization for determination of HER2 status in breast cancer: a large comparative study to current state of the art fluorescence in situ hybridization

Jens Mollerup*, Ulla Henriksen, Sven Müller and Andreas Schønau

BMC Clinical Pathology 2012, 12:3  doi:10.1186/1472-6890-12-3

Article Metrics

4715
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 93 accesses
  • Last 365 days: 947 accesses
  • All time: 4715 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information